DCM
BIOC

Driehaus Capital Management’s Biocept, Inc. BIOC Stock Holding History

Driehaus Capital Management’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,704
Closed -$493K – 535
2020
Q4 		$493K Buy
+3,704
New +$528K 0.01% 366

Other funds holding BIOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $87.6B AUM 131.08% 1-Year Est. Return
HSA
Hussman Strategic Advisors Ellicott City, Maryland $434M AUM 19.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Driehaus Capital Management's BIOC Position: Q1 2021 in Review

Driehaus Capital Management sold out of Biocept, Inc. (BIOC) in Q1 2021, closing a stake of 3,704 shares — an estimated $493K sold.

Driehaus Capital Management first reported a position in BIOC in Q4 2020 and held it in 1 quarter. The position peaked at $493K in Q4 2020. 22 funds tracked by Wall St. Rank hold BIOC as of Q1 2021.

  • Driehaus Capital Management reported no remaining Biocept, Inc. position as of Q1 2021 after selling out during the quarter.
  • Driehaus Capital Management sold 3,704 Biocept, Inc. shares in Q1 2021, an estimated $493K.
  • Driehaus Capital Management first reported a position in Biocept, Inc. in Q4 2020 and held it in 1 quarter.
  • Driehaus Capital Management's Biocept, Inc. position peaked at $493K in Q4 2020.
  • 22 funds tracked by Wall St. Rank held Biocept, Inc. as of Q1 2021.

Based on Driehaus Capital Management's 13F filing for Q1 2021, filed 17 May 2021.